Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New disc-based technologies for diagnostic and research applications.

Raj Barathur1, Jack Bookout, Srinand Sreevatsan

  • 1Burstein Technologies Inc., Irvine, California 92618, USA. rajbarathur@bursteinlabs.com

Psychiatric Genetics
|November 28, 2002
PubMed
Summary

This study introduces a novel nanotechnology platform using DNA microarrays in microchannels for advanced disease diagnostics and drug response analysis. This innovative approach promises rapid, low-cost, high-capacity screening for various genomic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to "Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical Properties".

ACS medicinal chemistry letters·2026
Same author

P2X7R-mediated IL-1β release by human brain tissue: the impact of CNS-penetrant potential therapeutics.

Brain : a journal of neurology·2026
Same author

Potent, Selective Pyrrolopyrimidine PDE11A4 Inhibitors with Improved Pharmaceutical Properties.

ACS medicinal chemistry letters·2026
Same author

Combinatorial chemistry identifies additional compounds that selectively inhibit DLK-dependent retrograde signaling while minimally affecting other axonal roles of DLK.

Scientific reports·2026
Same author

Fecal microbiota transplantation promotes type 2 mucosal immune responses with colonic epithelium proliferation in patients with recurrent Clostridioides difficile.

JCI insight·2025
Same author

RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors.

Journal of medicinal chemistry·2025

Area of Science:

  • Genomic Medicine
  • Nanotechnology Applications
  • Molecular Diagnostics

Background:

  • Genotypic analysis is crucial for disease diagnostics and predicting drug response.
  • Advancements in genomic discoveries and technologies are expanding testing capabilities.
  • Current diagnostic methods can be limited in speed, cost, and capacity.

Purpose of the Study:

  • To describe a novel nanotechnology-based platform for enhanced genomic analysis.
  • To explore the potential of integrating molecular and immunological applications.
  • To highlight the relevance of this technology for diverse applications.

Main Methods:

  • DNA microarrays integrated into a microchannel environment.
  • Analysis of microarrays using an optical (CD/DVD) disc drive system.

Related Experiment Videos

  • Development of a rapid, low-cost, high-capacity screening platform.

    • Main Results:

    • Demonstrated a functional nanotechnology platform for DNA microarray analysis.
    • Showcased the potential for combined molecular and immunological screening.
    • Identified applications in infectious agent detection, pharmacogenomics, and neurogenomics.

    Conclusions:

    • The described nanotechnology offers a versatile platform for advanced genomic analysis.
    • This approach has significant implications for personalized medicine and disease management.
    • Future applications include genetic variation analysis for neurologic diseases.